November 17, 2025 · Form 4 insider transaction
Atkinson Edward Morrow III sold 2,500 shares of Vertex Pharmaceuticals Incorporated at $434.58 per share, a transaction worth $1.09M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 08/11/2025.